PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 34659631-4 2021 Some studies have showed that ginsenoside Rg3 decelerated hERG K(+) channel tail current deactivation. ginsenoside Rg3 30-45 ETS transcription factor ERG Homo sapiens 58-62 34659631-5 2021 Therefore, in this study, we aim to confirm whether ginsenoside Rg3 targeting hERG K(+) channel could be used to reverse the vandetanib-induced QT interval prolongation. ginsenoside Rg3 52-67 ETS transcription factor ERG Homo sapiens 78-82 34659631-13 2021 Furthermore, ginsenoside Rg3 alleviated vandetanib-induced hERG current inhibition and accelerated the process of the channel activation. ginsenoside Rg3 13-28 ETS transcription factor ERG Homo sapiens 59-63 34659631-14 2021 Ginsenoside Rg3 may be a promising cardioprotective agent against vandetanib-induced QT interval prolongation through targeting hERG channel. ginsenoside Rg3 0-15 ETS transcription factor ERG Homo sapiens 128-132